United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

Published : Aug-2020

No. of Pages : 2761

order by fax Inquire before Buying request discount

1 Table of Contents
2 Introduction
3 In Vitro Diagnostics Market, United States
4 Cardiac Disease Market, United States
5 Clinical Chemistry Market, United States
6 Hematological Disorders Market, United States
7 Hormonal Disorders Market, United States
8 Infectious Disease Market, United States
9 IVD Analyzers and Reagents Market, United States
10 Metabolic Disorder Market, United States
11 Oncology Market, United States
12 Women's Health Market, United States
13 Overview of Key Companies in United States, In Vitro Diagnostics Market
14 In Vitro Diagnostics Market Pipeline Products
15 Financial Deals Landscape
16 Recent Developments
17 Appendix

List of Tables
Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2015-2025
Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2018
Table 3: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025
Table 6: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2015-2020
Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2021-2025
Table 8: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2018
Table 9: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Cardiac Disease Market, United States, Volume (Units), 2015-2020
Table 14: Cardiac Disease Market, United States, Volume (Units), 2021-2025
Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2015-2020
Table 16: Cardiac Marker Tests Market, United States, Volume (Units), 2021-2025
Table 17: Cardiac Disease Market, United States, Average Price ($), 2015-2020
Table 18: Cardiac Disease Market, United States, Average Price ($), 2021-2025
Table 19: Cardiac Disease Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018
Table 20: Cardiac Disease Market, United States, Company Share by Revenue ($m), USD Constant, 2018
Table 21: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 22: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 23: Substrates Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 24: Substrates Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 25: Clinical Chemistry Market, United States, Volume (Units), 2015-2020
Table 26: Clinical Chemistry Market, United States, Volume (Units), 2021-2025

List of Figures
Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2018
Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2018
Figure 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025
Figure 6: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2015-2025
Figure 7: In Vitro Diagnostics Market, United States, Company Share (%) 2018
Figure 8: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 9: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 10: Cardiac Disease Market, United States, Volume (Units), 2015-2025
Figure 11: Cardiac Marker Tests Market, United States, Volume (Units), 2015-2025
Figure 12: Cardiac Disease Market, United States, Company Share (%) 2018
Figure 13: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 14: Substrates Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 15: Clinical Chemistry Market, United States, Volume (Units), 2015-2025
Figure 16: Substrates Market, United States, Volume (Units), 2015-2025
Figure 17: Clinical Chemistry Market, United States, Company Share (%) 2018
Figure 18: Hematological Disorders Market, United States, Revenue Mix ($m), 2018
Figure 19: Hematological Disorders Market, United States, Segment Contribution (%), 2018
Figure 20: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 21: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 22: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 23: Hematological Disorders Market, United States, Volume (Units), 2015-2025
Figure 24: Hematology Tests Market, United States, Volume (Units), 2015-2025
Figure 25: Hemostasis Tests Market, United States, Volume (Units), 2015-2025
Figure 26: Hematological Disorders Market, United States, Company Share (%) 2018
Figure 27: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 28: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 29: Hormonal Disorders Market, United States, Volume (Units), 2015-2025
Figure 30: Thyroid Function Tests Market, United States, Volume (Units), 2015-2025
Figure 31: Hormonal Disorders Market, United States, Company Share (%) 2018
Figure 32: Infectious Disease Market, United States, Revenue Mix ($m), 2018
Figure 33: Infectious Disease Market, United States, Segment Contribution (%), 2018
Figure 34: Infectious Disease Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 35: Chlamydia Trachomatis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 36: Clostridium difficile Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 37: Cytomegalovirus (CMV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 38: Hepatitis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 40: Human Papilloma Virus (HPV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 42: Mycobacterium Tuberculosis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 43: Neisseria Gonorrhoeae Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 44: Treponema pallidum Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 45: Infectious Disease Market, United States, Volume (Units), 2015-2025
Figure 46: Chlamydia Trachomatis Tests Market, United States, Volume (Units), 2015-2025
Figure 47: Clostridium difficile Tests Market, United States, Volume (Units), 2015-2025
Figure 48: Cytomegalovirus (CMV) Tests Market, United States, Volume (Units), 2015-2025
Figure 49: Hepatitis Tests Market, United States, Volume (Units), 2015-2025
Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, United States, Volume (Units), 2015-2025

Filed in: Pharmaceuticals and Healthcare

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950
Digital Pathology Market by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) – Global Forecast to 2026 “The Digital Pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2021–2026).” The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics. On the other hand, the high costs of digital pathology systems are expected to restrain market growth to a certain extent. “The scanners segment accounted for the largest share of the Digital Pathology market in 2020.” Based on products,......	$4950
Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region – Global Forecasts to 2027 “The telehealth & telemedicine market is projected to grow at a CAGR of 26.6% during the forecast period (2022–2027).” The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022.The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during the forecast period. ......	$4950
Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers& Laboratories), COVID-19 Impact – Forecast to 2026 “A shortage of skilled radiologists & need for faster and improved diagnosis are driving market growth” The teleradiology market is expected to reach USD 14.8billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 15.3% during the forecast period of 2021 to 2026. Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for teleradiology services. The growth of this market is mainly attributed to the growth of the teleradiology market is driven by the rising geriatric population and the subsequent increase in the prevalence of associated diseases; the increasing number of advanced imaging procedures and a shortage of skilled radiologists; advancements in teleradiology the increasing adoption of cloud-based solutions. However, declining reimbursements a......	$4950
Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, HR & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2026 Global healthcare consulting services market is projected to grow at CAGR of 11.5%” The global healthcare consulting services market is projected to reach USD 41.2 billion by 2026 from USD 23.9 billion in 2021, at a CAGR of 11.5% during the forecast period. Healthcare consulting firms specialize in providing business consulting services to the healthcare industry in areas such as finance, accounting, marketing, insurance, healthcare management, billing, coding, regulations & compliance, healthcare standards, and many other similar areas. Growth in the healthcare consulting services market can be primarily attributed to the growing budget cuts, increasing pricing pressure, changing healthcare policies/regulations, and rising technological disruption across the healthcare industry t......	$4950
Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2026 “The global animal growth promoters and performance enhancers market is projected to grow at a CAGR of 5.7%” The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising......	$4950
Hemophilia A and B – Epidemiology Forecast to 2030 Hemophilia A and B - Epidemiology Forecast to 2030 Summary Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation because of deficiencies in the production or function of coagulation factor VIII in hemophilia A or factor IX in hemophilia B (Bolton-Maggs and Pasi, 2003). Because of the deficiency of coagulation factor, hemophilia patients have a tendency to bleed in joints, muscles, soft tissues, and within mucous membranes, which can be either spontaneous or due to internal or external trauma, depending on the severity of the disease (CDC, 2021; Mayo Clinic, 2021). According to the World Federation of Hemophilia (WFH), hemophilia is rare. About 1 in 10,000 people are born with hemophilia A and about 1 in 50,000 people are born with hemophilia B......	$3995

United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

Digital Pathology Market by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) – Global Forecast to 2026

Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region – Global Forecasts to 2027

Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers& Laboratories), COVID-19 Impact – Forecast to 2026

Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, HR & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2026

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2026

Hemophilia A and B – Epidemiology Forecast to 2030